Skip to main content
hello world

Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.

AtkinsRéalis Bolsters Canada's Vaccine Manufacturing Capacity with Design of $109 Million Facility

Newswire.ca - Thu Aug 29, 6:45AM CDT

MONTREAL, Aug. 29, 2024 /CNW/ - AtkinsRéalis Group Inc. (TSX: ATRL), a world-class engineering services and nuclear company with offices around the world, has won a mandate from Jubilant HollisterStier, a leading global pharmaceutical contract manufacturer, to provide detailed design for the expansion of their sterile injectable facility in Montreal as part of Canada's Biomanufacturing and Life Sciences Strategy pandemic preparedness plan to domestically manufacture and supply vaccines.

Read more at newswire.ca